Skip Ribbon Commands
Skip to main content

Clinical Trials Advisory Committee

Sharing knowledge. Sharing Hope.
Skip Navigation LinksHome   |   About CIBMTR   |   Who We Are   |   Committees   |   Other Administrative Committees   |   Clinical Trials Advisory Committee
  • Print
  • Share

Clinical Trials Advisory Committee

The Clinical Trials Advisory Committee (CTAC) is an independent advisory body for the CIBMTR Resource for Clinical Investigation in Blood and Marrow Transplant (RCI BMT) proposals. Its interdisciplinary membership has expertise in HCT and conducting clinical trials.


  • Assess submitted proposals for scientific merit, feasibility and alignment with scientific agenda
  • Advise the RCI BMT Clinical Trials Office (CTO) on priority of proposed studies
  • Review progress of ongoing studies


  • A minimum of ten members recommended by the CIBMTR Nominating Committee and/or elected by the CIBMTR Assembly 
  • Serve a three-year term, renewable one time
  • Adult and pediatric transplant physicians including persons versed in representing donor interest (i.e., transfusion medicine physician)
  • Non-physicians with experience in patient and donor issues (i.e., Chair of Consumer Advocacy Committee)
  • Consulting (ad hoc) members are individuals with specific expertise who may be invited by the CTAC chair to review a specific study. These (ad hoc) members have equal voting rights pertaining to the particular study
  • Ex-officio members include: RCI BMT Director, CIBMTR Sr. Manager – Prospective Research, CIBMTR PhD Statistician, Chief Medical Officer of the NMDP/Be The Match, CIBMTR Senior Research Advisor, CIBMTR Chief Scientific Director, and one additional Scientific Director


The Clinical Trials Advisory Committee meets at least annually, and may meet as often as quarterly, to review and provide recommendations regarding proposals.


Elected Members​ ​
Chair: John Levine, MD, MS, Mount Sinai Medical Center, New York, NY
​Members: Natalie Callander, MD, University of Wisconsin Hospital and Clinics, Madison, WI
Colleen Delaney, MD, MSc, Fred Hutchinson Cancer Research Center, Seattle, WA
Marcos de Lima, MD, University Hospitals Case Medical Center, Cleveland, OH
Stephan Grupp, MD, PhD, Children's Hospital of Philadelphia, Philadelphia, PA
John Koreth, MBBS, DPhil, Dana Farber Cancer Institute, Boston, MA
Margaret MacMillan, MD, MSc, University of Minnesota Medical Center, Fairview, Minneapolis, MN
Sophie Paczesny, MD, PhD, Indiana University Hospital/Riley Hospital for Children, Indianapolis, IN
Katy Rezvani, MD, PhD, M.D. Anderson Cancer Center, Houston, TX
​Appointed Members​
CIBMTR Consumer Advocacy Committee Co-Chairs
Maureen Beaman, BS, MBA ​Milwaukee, WI
Jim Omel, MD ​ ​Retired, Grand Island, NE
​Ex Officio Members​  ​
Dennis Confer, MD CIBMTR, Minneapolis, MN
Rebecca Drexler CIBMTR, Minneapolis, MN
Mary Horowitz, MD, MS CIBMTR, Milwaukee, WI
TBD Rockville, MD
Roberta King, MPH CIBMTR, Minneapolis, MN
Brent R. Logan, PhD  ​
CIBMTR, Milwaukee, WI
Nancy Poland, MA NMDP/Be The Match, Minneapolis, MN
Marcie Riches, MD, MS CIBMTR Scientific Director, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
Bronwen Shaw, MD, PhD
CIBMTR, Milwaukee, WI
Kevin Weber ​NMDP/Be The Match, Minneapolis, MN
Daniel Weisdorf, MD ​CIBMTR Senior Research Advisor, Minneapolis, MN

Last Updated: 11/8/2019 12:00 PM